Insufficient scRNA-seq data for expression of ANKRD13B at single-cell level.
Insufficient scRNA-seq data for expression of ANKRD13B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 3583.07 | 2641 / 2642 | 100% | 35.34 | 703 / 705 |
esophagus | 98% | 1092.49 | 1412 / 1445 | 95% | 16.21 | 174 / 183 |
bladder | 100% | 1281.95 | 21 / 21 | 92% | 12.69 | 464 / 504 |
breast | 99% | 999.74 | 454 / 459 | 92% | 11.60 | 1034 / 1118 |
skin | 98% | 831.27 | 1770 / 1809 | 93% | 12.37 | 438 / 472 |
prostate | 99% | 1015.79 | 242 / 245 | 91% | 7.04 | 457 / 502 |
uterus | 100% | 1793.81 | 170 / 170 | 88% | 12.57 | 406 / 459 |
intestine | 89% | 937.77 | 855 / 966 | 95% | 13.15 | 503 / 527 |
ovary | 100% | 1734.69 | 180 / 180 | 77% | 7.63 | 330 / 430 |
lung | 89% | 646.32 | 517 / 578 | 79% | 10.23 | 916 / 1155 |
stomach | 61% | 435.59 | 220 / 359 | 93% | 13.43 | 266 / 286 |
adrenal gland | 67% | 375.22 | 173 / 258 | 79% | 9.60 | 182 / 230 |
thymus | 95% | 758.09 | 623 / 653 | 51% | 3.00 | 306 / 605 |
pancreas | 27% | 126.61 | 87 / 328 | 88% | 7.09 | 157 / 178 |
ureter | 0% | 0 | 0 / 0 | 100% | 15.27 | 1 / 1 |
adipose | 99% | 1266.13 | 1188 / 1204 | 0% | 0 | 0 / 0 |
kidney | 34% | 216.65 | 30 / 89 | 63% | 5.04 | 568 / 901 |
blood vessel | 94% | 772.37 | 1249 / 1335 | 0% | 0 | 0 / 0 |
heart | 91% | 738.21 | 784 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 10.88 | 40 / 45 |
muscle | 87% | 716.61 | 700 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 80% | 6.16 | 64 / 80 |
lymph node | 0% | 0 | 0 / 0 | 69% | 5.45 | 20 / 29 |
spleen | 42% | 190.65 | 102 / 241 | 0% | 0 | 0 / 0 |
liver | 2% | 7.86 | 4 / 226 | 19% | 1.40 | 79 / 406 |
peripheral blood | 7% | 31.92 | 61 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002091 | Biological process | negative regulation of receptor internalization |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005770 | Cellular component | late endosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0005769 | Cellular component | early endosome |
GO_0140036 | Molecular function | ubiquitin-modified protein reader activity |
Gene name | ANKRD13B |
Protein name | Ankyrin repeat domain 13B Ankyrin repeat domain-containing protein 13B ANKRD13B protein |
Synonyms | |
Description | FUNCTION: Ubiquitin-binding protein that specifically recognizes and binds 'Lys-63'-linked ubiquitin. Does not bind 'Lys-48'-linked ubiquitin. Positively regulates the internalization of ligand-activated EGFR by binding to the Ub moiety of ubiquitinated EGFR at the cell membrane. . FUNCTION: Ubiquitin-binding protein that specifically recognizes and binds 'Lys-63'-linked ubiquitin. Does not bind 'Lys-48'-linked ubiquitin. Positively regulates the internalization of ligand-activated EGFR by binding to the Ub moiety of ubiquitinated EGFR at the cell membrane. . |
Accessions | ENST00000614878.4 [Q86YJ7-1] Q86YJ7 Q6P5X6 K7EKP0 K7ENT0 ENST00000488766.5 [Q86YJ7-1] ENST00000394859.8 [Q86YJ7-1] ENST00000579719.1 ENST00000583728.5 |